Good Laboratory Practices

In August 2016, the FDA published—and is currently evaluating—a polished set of proposed Good Laboratory Practices (GLP) management. They are currently leading monitoring reviews of laboratories, testing situations, and CROs to assure that buildings comply with GLP and can manage data sincerity for their examinations. If a Study Director does not have the capacity to ensure both GLP agreement and data honesty, they can be directed to a Form 483, other Warning Letters, and